These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 28338199

  • 1. MiR-576-3p is a novel marker correlated with poor clinical outcome in bladder cancer.
    Meng FM, Meng FM, Song XL.
    Eur Rev Med Pharmacol Sci; 2017 Mar; 21(5):973-977. PubMed ID: 28338199
    [Abstract] [Full Text] [Related]

  • 2. MicroRNA-148a represents an independent prognostic marker in bladder cancer.
    Ma L, Xu Z, Xu C, Jiang X.
    Tumour Biol; 2016 Jun; 37(6):7915-20. PubMed ID: 26700670
    [Abstract] [Full Text] [Related]

  • 3. Expression of microRNA-142-3p in cervical cancer and its correlation with prognosis.
    Li M, Li BY, Xia H, Jiang LL.
    Eur Rev Med Pharmacol Sci; 2017 May; 21(10):2346-2350. PubMed ID: 28617557
    [Abstract] [Full Text] [Related]

  • 4. Increased expression of miR-330-3p: a novel independent indicator of poor prognosis in human breast cancer.
    Wang H, Chen SH, Kong P, Zhang LY, Zhang LL, Zhang NQ, Gu H.
    Eur Rev Med Pharmacol Sci; 2018 Mar; 22(6):1726-1730. PubMed ID: 29630118
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Low expression of miR-409-3p is a prognostic marker for breast cancer.
    Cao GH, Sun XL, Wu F, Chen WF, Li JQ, Hu WC.
    Eur Rev Med Pharmacol Sci; 2016 Sep; 20(18):3825-3829. PubMed ID: 27735035
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Down-regulation of miR-1236-3p is correlated with clinical progression and unfavorable prognosis in gastric cancer.
    Zhu XP, Wang XL, Ma J, Fang YF, Zhang HJ, Zhang C, Feng MC.
    Eur Rev Med Pharmacol Sci; 2018 Sep; 22(18):5914-5919. PubMed ID: 30280772
    [Abstract] [Full Text] [Related]

  • 13. Decreased expression of miR-490-3p in osteosarcoma and its clinical significance.
    Tang B, Liu C, Zhang QM, Ni M.
    Eur Rev Med Pharmacol Sci; 2017 Jan; 21(2):246-251. PubMed ID: 28165565
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Decreased expression of microRNA-124 is an independent unfavorable prognostic factor for patients with breast cancer.
    Dong LL, Chen LM, Wang WM, Zhang LM.
    Diagn Pathol; 2015 Apr 29; 10():45. PubMed ID: 25924779
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of miR-182/miR-100 Ratio for Diagnosis and Survival Prediction in Bladder Cancer.
    Chen Z, Wu L, Lin Q, Shi J, Lin X, Shi L.
    Arch Iran Med; 2016 Sep 29; 19(9):645-51. PubMed ID: 27631180
    [Abstract] [Full Text] [Related]

  • 19. Downregulation of tissue miR-338-3p predicts unfavorable prognosis of gastric cancer.
    Liu S, Suo J, Wang C, Sun X, Wang D, He L, Zhang Y, Li W.
    Cancer Biomark; 2017 Dec 12; 21(1):117-122. PubMed ID: 29060930
    [Abstract] [Full Text] [Related]

  • 20. miR-199a-3p and miR-214-3p improve the overall survival prediction of muscle-invasive bladder cancer patients after radical cystectomy.
    Ecke TH, Stier K, Weickmann S, Zhao Z, Buckendahl L, Stephan C, Kilic E, Jung K.
    Cancer Med; 2017 Oct 12; 6(10):2252-2262. PubMed ID: 28879675
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.